NCT01307852View on ClinicalTrials.gov

In Vivo Dosimetry During Prostate Cancer Radiotherapy

PHASE1CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Prostate Disease
Interventions
DEVICE

Plastic Scintillation Detectors

Radiation detectors attached to rectal balloon for each CT scan done during each radiation treatment. Treatment delivery Monday through Friday for 7 weeks.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

M.D. Anderson Cancer Center

OTHER

NCT01307852 - In Vivo Dosimetry During Prostate Cancer Radiotherapy | Biotech Hunter | Biotech Hunter